Page - (000145) - in Biomedical Chemistry: Current Trends and Developments

Kimball, A. B., Jacobson, C., Weiss, S., Vreeland, M. G., & Wu, Y. (2005). The psychosocial burden of psoriasis. American Journal of Clinical Dermatology, 6(6), 383-392. Kraus, M. R., Schafer, A., Faller, H., Csef, H., & Scheurlen, M. (2003). Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. Journal of Clinical Psychiatry, 64(6), 708-714. Kronfol, Z., & Remick, D. G. (2000). Cytokines and the brain: implications for clinical psychiatry. American Journal of Psychiatry, 157(5), 683-694. Kubera, M., Lin, A. H., Kenis, G., Bosmans, E., van Bockstaele, D., & Maes, M. (2001). Anti- Inflammatory effects of antidepressants through suppression of the interferon- gamma/interleukin-10 production ratio. Journal of Clinical Psychopharmacology, 21(2), 199- 206. LeDoux, J. E. (1995). Emotion: clues from the brain. Annual Review of Psychology, 46, 209-235. doi: 10.1146/annurev.ps.46.020195.001233 Leonard, B. E. (2001). The immune system, depression and the action of antidepressants. Progress in Neuropsychopharmacology & Biological Psychiatry, 25(4), 767-780. Licinio, J., O’Kirwan, F., Irizarry, K., Merriman, B., Thakur, S., Jepson, R., Wong, M. L. (2004). Association of a corticotropin-releasing hormone receptor 1 haplotype and antidepressant treatment response in Mexican-Americans. Molecular Psychiatry, 9(12), 1075-1082. doi: 10.1038/sj.mp.4001587 Licinio, J., & Wong, M. L. (1999). The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Molecular Psychiatry, 4(4), 317-327. Licinio, J., & Wong, M. L. (2011). Advances in depression research: 2011. Molecular Psychiatry, 16(7), 686-687. doi: 10.1038/mp.2011.74 Licinio, J., Wong, M. L., & Gold, P. W. (1991). Localization of interleukin-1 receptor antagonist mRNA in rat brain. Endocrinology, 129(1), 562-564. doi: 10.1210/endo-129-1-562 Licinio, J., Wong, M. L., & Gold, P. W. (1992). Neutrophil-activating peptide-1/interleukin-8 mRNA is localized in rat hypothalamus and hippocampus. Neuroreport, 3(9), 753-756. Loftis, J. M., Hauser, P., Macey, T. A., & Lowe, J. D. (2006). Can rodents be used to model interferon-alpha-induced depressive symptoms? Progress in Neuropsychopharmacology & Biological Psychiatry, 30(7), 1364-1365; author reply 1366. doi: 10.1016/j.pnpbp.2006.04.004 Lohoff, F. W. (2010). Overview of the genetics of major depressive disorder. Current Psychiatry Reports, 12(6), 539-546. doi: 10.1007/s11920-010-0150-6 Lopez, A. D., & Murray, C. C. (1998). The global burden of disease, 1990-2020. Nature Medicine, 4(11), 1241-1243. doi: 10.1038/3218 Maes, M., Song, C., Lin, A. H., Bonaccorso, S., Kenis, G., De Jongh, R., . . . Scharpe, S. (1999). Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology, 20(4), 370-379. doi: 10.1016/S0893-133X(98)00088-8 Maes, M., Verkerk, R., Bonaccorso, S., Ombelet, W., Bosmans, E., & Scharpe, S. (2002). Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune